Observational study of cenegermin for the treatment of limbal stem cell deficiency associated with neurotrophic keratopathy.
Alejandro ArboledaChristopher N TaPublished in: Therapeutic advances in ophthalmology (2022)
The study was registered at ClinicalTrials.gov with identifier NCT04552730 (https://clinicaltrials.gov/ct2/show/NCT04552730).